Synthetic technology of azelastine hydrochloride

A technology of azelastine hydrochloride and synthesis process, which is applied in directions such as organic chemistry, can solve the problems of low yield and difficulty in obtaining raw materials, and achieves the effects of high yield and simple process
CN102391253AInactive Publication Date: 2012-03-28GUIZHOU YUNFENG PHARMA

Patent Information

Authority / Receiving Office
CN · China
Current Assignee / Owner
GUIZHOU YUNFENG PHARMA
Publication Date
2012-03-28
Estimated Expiration
Not applicable · inactive patent
Patent Text Reader

Abstract

The invention discloses a synthetic technology of azelastine hydrochloride, which is characterized in that acylhydrazone is formed by N-Methylhexahydroazepin-4-one hydrochloride and benzoyl hydrazine and then is reduced with potassium borohydride, and finally is condensed with 2-(para chlorobenzene acetyl) benzoic acid into 4-( chlorine benzyl)-2-piperazidine-1- methyl-1H-azelastine-4- radical)-1-(2H)-phthalazine hydrochloride. The synthetic technology has the advantages of simple process and higher yield.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention belongs to the field of fine chemical production, and in particular relates to a synthesis process of azelastine hydrochloride. Background technique

[0002] The chemical formula of azelastine hydrochloride is 4-(4-chlorobenzyl)-2-(hexahydro-1-methyl-1H-azepine-4-yl)-1-(2H)-phthalazine hydrochloride , was developed by Asta-Werker AG of Germany and Eisai of Japan, and has received extensive attention since its listing. At present, the product is produced in the United States, Germany, Britain, Japan and France, and has been included in the British Pharmacopoeia. It is expected that the launch of the new anti-asthma drug azelastine hydrochloride will greatly change the current drug structure for the treatment of allergic rhinitis and asthma. It has huge market space and prospects, and the research on its technology is of great significance.

[0003] Chinese Journal of Pharmaceutical Industry reported in 2003 that N-methylpiperidin-4-one ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More